Charles Stacey
AeroLeads people directory · profile

Charles Stacey Email & Phone Number

Biotech CEO | Life Science Investor | Health Futurist at Cerecin
Location: Singapore, Singapore, Singapore 16 work roles 7 schools
1 work email found @cerecin.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email c****@cerecin.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Biotech CEO | Life Science Investor | Health Futurist
Location
Singapore, Singapore, Singapore

Who is Charles Stacey? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Charles Stacey is listed as Biotech CEO | Life Science Investor | Health Futurist at Cerecin, based in Singapore, Singapore, Singapore. AeroLeads shows a work email signal at cerecin.com and a matched LinkedIn profile for Charles Stacey.

Charles Stacey previously worked as President and CEO at Cerecin and President and CEO (Accera Pharmaceuticals) at Cerecin. Charles Stacey holds Mba, Exchange Programme With Wharton Business School from London Business School.

Company email context

Email format at Cerecin

This section adds company-level context without repeating Charles Stacey's masked contact details.

{first_initial}{last}@cerecin.com
86% confidence

AeroLeads found 1 current-domain work email signal for Charles Stacey. Compare company email patterns before reaching out.

Profile bio

About Charles Stacey

Charles has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He now leverages this breadth of experience in leading Cerecin in the fight against neurological diseases and brain health.Prior to joining Cerecin, Charles was with Inventages, a global healthcare venture capital and private equity group with $1.5 billion under management. Inventages was one of the world's first and leading funds with a focus on nutrition and wellness. Charles managed all stages of the investment life cycle: deal sourcing, due diligence and supporting portfolio companies. Charles has a specialist interest and particular experience in investments in the brain health, digital health and emerging markets (particularly Asia). Earlier in his career, Charles co-founded a medical device company to develop a product that he invented through the course of his clinical work as a trauma surgeon. During this time he also consulted to other healthcare start ups and Safeguard Scientific, a US-based venture capital firm. Before this Charles worked as an orthopedic and reconstructive surgeon in London specializing in lower limb and hand surgery. Charles received his medical degree from King’s College London and trained in general medical and surgical specialties in London/Surrey, UK. He also has a BSc in Neuroscience from University College London, an MSc in Surgical Technology from Imperial College and an MBA from the London Business School and the Wharton School.

Listed skills include Healthcare, Clinical Research, Venture Capital, Pharmaceutical Industry, and 20 others.

Current workplace

Charles Stacey's current company

Company context helps verify the profile and gives searchers a useful next step.

Cerecin
Cerecin
Biotech CEO | Life Science Investor | Health Futurist
AeroLeads page
16 roles · 24 years

Charles Stacey work experience

A career timeline built from the work history available for this profile.

President And Ceo

Current

Central Business District, SG

Cerecin, Inc., is a privately held biotech company that develops therapies to treat central nervous system disorders. The lead candidate, Tricaprilin is currently in late stage clinical trials for mild-moderate Alzheimer's disease. [Charles held the role of interim-CEO from January to September 2014]

Mar 2018 - Present

President And Ceo (Accera Pharmaceuticals)

Central Business District, SG

Feb 2015 - Mar 2018

Industry Advisory Panel (Iap)

Current

co11ab Novena is a BioMedTech incubator – a tripartite alliance between Nanyang Technological University NTU, Singapore, Agency for Science, Technology, and Research (A*STAR), and National Healthcare Group (NHG).

Jun 2024 - Present

Venture Partner

Current

Calgary, Alberta, CA

One Six 8 Ventures is a venture capital firm based in Western Canada. Our seasoned team of industry executives and investors provide support to early-stage health and life sciences companies within the Canadian ecosystem. Our mission is to nurture innovation and accelerate the growth of promising startups.

Mar 2024 - Present

Member Of Board Of Governors

Current

Greater New York Area, New Jersey, US

Accreditation Council for Medical Affairs is a self-governing, independent organization which promotes standards of excellence around both core technical competencies and ethical practices for pharmaceutical industry professionals in medical affairs.

Sep 2018 - Present

Guest Lecturer

Current

Singapore, Singapore, SG

Guest lecturer @ Lee Kong Chian School of Medicine, NTU- Bio-Entrepreneurship Course - LKCMed Year 2 Innovations in Medicine Lecture

Oct 2020 - Present

Executive Committee Member

Current
Ypo, Singapore

Executive Committee Member, YPO Singapore Integrated

Nov 2020 - Present

Investor

Current

Brighton, GB

Nov 2023 - Present

Founder Chairman

Alzheimer'S Association Business Consortium (Aabc)

Founded in 2015, the mission of the AABC is to support the advancement of Alzheimer’s disease research and innovation in small companies.

2015 - Jan 2018

Board Of Directors, Member

Gc-Rise Pharmaceuticals

A leading Chinese pharmaceutical company specialising in women's and children's health. GC-Rise has a sales force of over 500 sales reps enabling access to the majority of the Chinese market. GC-Rise has won the Deloitte's 50 Top-performing Company Award for 3 consecutive years (the only pharmaceutical company to receive this award in 2013).

Feb 2011 - Jun 2015

Senior Investment Manager

CH

One of the largest healthcare venture capital and private equity groups with $1.5 billion under management. Inventages has a particular focus on therapeutics for chronic chronic disease, wellness/longevity and preventative health. Charles has responsibility for five portfolio companies and has led/supported six equity transactions (inc. follow on.

2010 - Feb 2015

Board Of Directors, Observer

Cognoptix Inc

Cognoptix, a company headquartered in Acton, Mass., is focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer’s Disease. The feasibility study showed unprecedented accuracy, with a specificity of 95% and sensitivity of 85% at differentiating Alzheimer's disease patients from.

Jun 2011 - Nov 2014

Chief Medical Officer & Business Development

Myoton

Chief Medical Officer to Myoton, a European medical device company with novel CNS diagnostic device. Leading of clinical strategy and development of clinical collaborations and trials at top UK clinical sites including the Institute of Neurology, Queen Square.

Mar 2009 - Oct 2010

Co-Founder, Co-President And Medical Lead

Flexycast Ltd

Founded a company to develop and commercialize a novel orthopaedic splinting technology that was invented through the course of clinical practice. Raised equity funding and built a multidisciplinary team, consisting of design, engineering, IP and regulatory expertise.

2008 - Oct 2010

Trauma And Reconstructive Surgeon

Nhs

GB

Charles worked as an orthopedic and reconstructive surgeon at leading teaching hospitals in London and South East England.

2002 - Aug 2009
7 education records

Charles Stacey education

Mba, Exchange Programme With Wharton Business School

London Business School

Mba (Healthcare), Exchange Program From Lbs

The Wharton School

Mrcs, Member Of Royal College Of The Surgeons

Royal College Of Surgeons Of England

Msc, Surgical Technology, Prof A. Darzi

Imperial College London

Mbbs, Medicine

King'S College London

Bsc, Neuroscience

Ucl

Education record

Tonbridge School, Kent
FAQ

Frequently asked questions about Charles Stacey

Quick answers generated from the profile data available on this page.

What company does Charles Stacey work for?

Charles Stacey works for Cerecin.

What is Charles Stacey's role at Cerecin?

Charles Stacey is listed as Biotech CEO | Life Science Investor | Health Futurist at Cerecin.

What is Charles Stacey's email address?

AeroLeads has found 1 work email signal at @cerecin.com for Charles Stacey at Cerecin.

Where is Charles Stacey based?

Charles Stacey is based in Singapore, Singapore, Singapore while working with Cerecin.

What companies has Charles Stacey worked for?

Charles Stacey has worked for Cerecin, Co11Ab Novena, One Six 8 Ventures, Accreditation Council For Medical Affairs (Acma), and Nanyang Technological University Singapore.

How can I contact Charles Stacey?

You can use AeroLeads to view verified contact signals for Charles Stacey at Cerecin, including work email, phone, and LinkedIn data when available.

What schools did Charles Stacey attend?

Charles Stacey holds Mba, Exchange Programme With Wharton Business School from London Business School.

What skills is Charles Stacey known for?

Charles Stacey is listed with skills including Healthcare, Clinical Research, Venture Capital, Pharmaceutical Industry, Private Equity, Orthopedic, Lifesciences, and Hardware Diagnostics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.